Processa Pharmaceuticals (PCSA) Total Debt (2012 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Total Debt came in at $1772.0 in Q4 2021, down 98.46% YoY from $114743.0 in Q4 2020, and down 84.91% on a QoQ basis from $11742.0 in Q2 2021.
Processa Pharmaceuticals (PCSA) Total Debt (2012 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 10 years of Total Debt data on file, last reported at $1772.0 in Q4 2021.
- Quarterly Total Debt fell 98.46% year-over-year to $1772.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1772.0 (down 98.46% YoY) and the FY2021 annual result came in at $1772.0, down 98.46% from the prior year.
- Total Debt fell to $1772.0 in Q4 2021, from $11742.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $2.6 million in Q4 2017 to a low of $100.0 in Q3 2018.
- A 5-year average of $597607.2 and a median of $230000.0 in 2019 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2018 — Total Debt tumbled 99.83% — and 2020, when it jumped 44080.84%.
- Tracing PCSA's Total Debt over 5 years: stood at $2.6 million in 2017, then tumbled by 82.17% to $460000.0 in 2018, then jumped by 249.46% to $1.6 million in 2019, then sank by 92.86% to $114743.0 in 2020, then sank by 98.46% to $1772.0 in 2021.
- The last three Total Debt figures came in at $1772.0 (Q4 2021), $11742.0 (Q2 2021), and $58829.0 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1,772.00 |
| Jun 30, 2021 | 11,742.00 |
| Mar 31, 2021 | 58,829.00 |
| Dec 31, 2020 | 114,743.00 |
| Sep 30, 2020 | 1.57 Mn |
| Jun 30, 2020 | 590,256.00 |
| Mar 31, 2020 | 1.61 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Sep 30, 2019 | 25,727.00 |
| Jun 30, 2019 | 1,336.00 |
| Mar 31, 2019 | 230,000.00 |
| Dec 31, 2018 | 460,000.00 |
| Sep 30, 2018 | 100.00 |
| Jun 30, 2018 | 1,116.00 |
| Dec 31, 2017 | 2.58 Mn |
| Jun 30, 2017 | 649,980.00 |
| Mar 31, 2017 | 649,980.00 |
| Dec 31, 2016 | 649,980.00 |
| Sep 30, 2016 | 1.84 Mn |
| Jun 30, 2016 | 1.84 Mn |